Literature DB >> 3301895

Kinetics study of immunological response to Clostridium botulinum toxin.

M Dezfulian, R A Bitar, J G Bartlett.   

Abstract

A double-antibody enzyme-linked immunosorbent assay (ELISA) for detection of humoral antibody to type A botulinal toxin was developed. This assay was used to study the kinetics of antibody response of a volunteer to botulinal toxoid. The circulating type A antitoxin was first detected by the ELISA 2 weeks after the first booster injection of the toxoid. The antibody titer stayed level until the second booster at 12 weeks. The titer then continued to rise throughout the remaining study period. The neutralizing antibody to type A toxin was detected by mouse assay 15 weeks after detection of antitoxin by the ELISA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301895      PMCID: PMC269211          DOI: 10.1128/jcm.25.7.1336-1337.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  The most poisonous poison.

Authors:  C LAMANNA
Journal:  Science       Date:  1959-09-25       Impact factor: 47.728

2.  Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.

Authors:  M Dezfulian; J G Bartlett
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

3.  Serum antibody response to Clostridium botulinum toxin in infant botulism.

Authors:  L G Rubin; M Dezfulian; R H Yolken
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

4.  Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.

Authors:  C H Hatheway; J D Snyder; J E Seals; T A Edell; G E Lewis
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

  4 in total
  3 in total

1.  Immunological response to Clostridium botulinum toxin.

Authors:  A Galazka; D Rymkiewicz; J Aleksandrowicz
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

Review 2.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay.

Authors:  L S Siegel
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.